Color Overview
- Status
-
Private
- Employees
-
612

- Latest Deal Type
-
Series E
- Latest Deal Amount
-
$100M
- Investors
-
73
Color General Information
Description
Developer of population care delivery device designed to assist durable and equitable public health across entire populations. The company offers health programs, state public health departments, solves healthcare logistics problems by centralizing all the core capabilities needed to deliver healthcare into one proven model, opening up diverse market opportunities and revenue streams, enabling clinical teams to use cases like testing, screening, treatment and referrals .
Contact Information
Website
www.color.com
Formerly Known As
Color Global, Color Genomics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Other Healthcare Services
Primary Office
- 831 Mitten Road
- Burlingame, CA 94010
- United States
+1 (650) 000-0000
Color Timeline
Color Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
9. Later Stage VC (Series E) | 09-Nov-2021 | $100M | 00000 | 00.00 | Completed | Generating Revenue |
8. Secondary Transaction - Private | 00000 | Completed | Generating Revenue | |||
7. Later Stage VC (Series D) | 04-Jan-2021 | 00000 | 00000 | 00.00 | Completed | Generating Revenue |
6. Grant | 21-Aug-2019 | 00.00 | 000.00 | Completed | Generating Revenue | |
5. Grant | 20-Aug-2019 | 000.00 | 000.00 | Completed | Generating Revenue | |
4. Grant | 20-Aug-2019 | 00.000 | 000.00 | Completed | Generating Revenue | |
3. Later Stage VC (Series C) | 01-Oct-2017 | 000.00 | 000.00 | 00000 | Completed | Generating Revenue |
2. Later Stage VC (Series B) | 27-Sep-2016 | $47.4M | $69.9M | 00000 | Completed | Generating Revenue |
1. Early Stage VC (Series A) | 15-May-2015 | $22.5M | $22.5M | 000.00 | Completed | Generating Revenue |
Color Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series E | 0,000,000 | 00.000000 | 00 | 000.00 | 000.00 | 00 | 000.00 | 0.000 |
Series D1 | 0,000,000 | 00.000000 | 00.00 | 000.00 | 000.00 | 00 | 000.00 | 0.000 |
Series D | 0,000,000 | 00.000000 | 00.00 | 000.00 | 000.00 | 00 | 000.00 | 0.000 |
Series C1 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
Series C | 0,000,000 | 00.000000 | 00.00 | 000.00 | 000.00 | 00 | 000.00 | 00.000 |
Series B | 7,359,259 | $0.000100 | $0.39 | $6.44 | $6.44 | 1x | $6.44 | 15.99% |
Series A | 6,507,991 | $0.000100 | $0.21 | $3.46 | $3.46 | 1x | $3.46 | 14.14% |
Color Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of population care delivery device designed to assist durable and equitable public health across entire popula
Diagnostic Equipment
Burlingame, CA
612
As of 2023
00000
0.00
0000-00-00
00000000000
00000
Color Competitors (8)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Transcarent | Venture Capital-Backed | Denver, CO | 000 | 00000 | 00000000000 | 00000 |
00000000000000 | Venture Capital-Backed | Dublin, Ireland | 000 | 00000 | 000000000 | 00000 |
00000 | Private Equity-Backed | Eden Prairie, MN | 000000 | 000.00 | 000000000000 | 000.00 |
000000 000000 | Private Equity-Backed | Lincoln, United Kingdom | 00 | 000000000000 | ||
000000000 | Corporation | Dublin, Ireland | 000000 | 00.000 | 00000000 | 00.000 |
Color Patents
Color Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-11718848-B1 | Methods for depletion of high-copy sequences in multiplexed whole genome sequencing libraries | Active | 29-May-2020 | 00000000000 | 0 |
US-20210232934-A1 | Systems and methods for enhanced user specific predictions using machine learning techniques | Active | 28-Jan-2020 | 00000000 | |
US-11599800-B2 | Systems and methods for enhanced user specific predictions using machine learning techniques | Active | 28-Jan-2020 | 000000000 | 0 |
US-20200135300-A1 | Applying low coverage whole genome sequencing for intelligent genomic routing | Pending | 26-Oct-2018 | 000000000 | 0 |
US-9811439-B1 | Functional testing of code modifications for read processing systems | Active | 18-Apr-2016 | G06F11/3612 |
Color Executive Team (21)
Color Board Members (5)
Name | Representing | Role | Since |
---|---|---|---|
Ann Mather | Self | Board Member | 000 0000 |
Elad Gil Ph.D | Color | Co-Founder & Chairman | 000 0000 |
Hemant Taneja | Self | Board Member | 000 0000 |
Othman Laraki | Color | Co-Founder, Chief Executive Officer, President and Board Member | 000 0000 |
Susan Wagner | Self | Board Member | 000 0000 |
Color Signals
Color Investors (73)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Agnostic Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Crescent Cove Advisors | PE/Buyout | Minority | 000 0000 | 000000 0 | |
Homebrew | Venture Capital | Minority | 000 0000 | 000000 0 | |
MSA Capital (Family Office) | Family Office | Minority | 000 0000 | 000000 0 | |
Quiet Capital | Venture Capital | Minority | 000 0000 | 000000 0 |
Color Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000 0000000 | 27-Oct-2022 | 0000000000 | Clinics/Outpatient Services | 000000 00 |
Color Subsidiaries (1)
Company Name | Industry | Location | Founded |
---|---|---|---|
0000 0000000 | Clinics/Outpatient Services | Ann Arbor, MI | 0000 |